Harrison Seth Loring

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$103.74M
Insider Sells Quantity
5
Insider Sells Sum
$15.06M

Insider Activity of Harrison Seth Loring

The largest purchase of all time was on 2020-07-10 and amounted to 830000 shares of Akero Therapeutics, Inc. for $29.88M.

The largest sale of all time was on 2022-10-26 and amounted to 137468 shares of Akero Therapeutics, Inc. for $6.01M.

Biography of Harrison Seth Loring

No biography is available at this moment.

2022-11-30SaleAkero Therapeutics, Inc.
AKRO
director
23,131
0.0499%
$46.94$1.09M-3.51%
2022-10-28SaleAkero Therapeutics, Inc.
AKRO
director
44,103
0.0932%
$40.31$1.78M+10.27%
2022-10-27SaleAkero Therapeutics, Inc.
AKRO
director
138,598
0.3005%
$41.53$5.76M+9.82%
2022-10-26SaleAkero Therapeutics, Inc.
AKRO
director
137,468
0.301%
$43.75$6.01M+5.33%
2022-10-25SaleAkero Therapeutics, Inc.
AKRO
director
9,421
0.0206%
$44.92$423,156+2.42%
2020-11-24PurchaseStoke Therapeutics, Inc.
STOK
375,000
0.9287%
$39.00$14.63M-27.6%
2020-07-10PurchaseAkero Therapeutics, Inc.
AKRO
830,000
2.3328%
$36.00$29.88M-22.54%
2019-06-24PurchaseAkero Therapeutics, Inc.
AKRO
1.8M
46.2798%
$16.00$28.8M+13.18%
2019-06-21PurchaseStoke Therapeutics, Inc.
STOK
1.39M
18.0204%
$18.00$25M-8.54%
2014-09-22PurchaseEledon Pharmaceuticals, Inc.
ELDN
362,500
12.71%
$15.00$5.44M-25.73%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.